Dana-Farber Presents Phase 3 Lung Cancer Data in ESMO Presidential Symposium (IMAGE)

Dana-Farber Cancer Institute

Dana-Farber Presents Phase 3 Lung Cancer Data in ESMO Presidential Symposium

Caption

Dana-Farber Cancer Institute researchers will present findings at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain. The studies, including a lung cancer clinical trial featured in the Presidential Symposium, will be presented both in-person and online from October 23 to October 27. Additional studies with compelling results span multiple cancer types, including prostate, breast, and kidney.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.